Browse by Administration Route

This page shows data for Intranasal virus.
Total Entries Retrieved: 20
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10082 FluMist Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Live-attenuated Approved AstraZeneca plc 2003 Canada 2 - 49 years Single dose Intranasal NA Hemagglutinin Egg based US FDA NA NA Tamiflu, Relenza NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10153 AdCOVID COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Phase 1 Altimmune Inc. NA USA 18 - 55 years NA Intranasal NA NA NA NA NA NA NA 33937326 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082173/ NA
10160 CVXGA1 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Phase 1 CyanVac LLC 2021 USA 18 - 75 years Single dose Intranasal NA Spike protein of SARS-CoV-2 virus NA US FDA NA NA PIV5-SARS CoV-2 vaccine NA NCT04954287 https://clinicaltrials.gov/ct2/show/NCT04954287 NA
10162 COVI-VAC COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Phase 1 Codagenix Inc. 2021 UK 18 - 30 years 2 doses 28 days apart Intranasal NA SARS CoV 2 whole virus NA NA Serum Institute of India NA CDX-005 33816047 NCT04619628 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ NA
10175 MV-014-212 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Phase 1 Meissa Vaccines Inc. 2021 USA 18 - 69 years 2 doses 35 days apart Intranasal NA Spike protein of SARS-CoV-2 virus NA NA NA NA NA NA NCT04798001 https://clinicaltrials.gov/ct2/show/NCT04798001?term=covid-19+vaccine&draw=2 NA
10180 iNCOVACC COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Phase 1 Bharat Biotech International Limited 2021 India 18 - 60 years 2 doses 28 days apart Intranasal NA Spike protein of SARS-CoV-2 virus NA NA NA NA BBV154 NA NA http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51327 NA
10204 HPIV3-EBO-Z ( HPIV3-EbovZ GP Vaccine) Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Virus like particle Phase 1 Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health 2015 USA 18 - 50 years NA Intranasal NA Zaire Ebola virus glycoprotein Live-attenuated human Parainfluenza virus type 3 vectored vaccine expressing Ebolavirus Zaire glycoprotein NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT02564575 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10216 Ad-CHIKV-SG Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Virus like particle Phase 1 NA NA NA NA Single dose Intranasal NA CHIKV structural proteins NA NA NA NA Ad-CHIKV-E3/E2/6K, Ad-CHIKV-E3/E2/E1 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10235 VXA G1.1 NN Norovirus Infection Gastrointestinal Norovirus positive-sense, single-stranded RNA Virus like particle Phase 1 Vaxart NA USA NA NA Intranasal NA HuNoV GII.4 NA NA NA NA NA NA NA https://www.mdpi.com/2076-393X/9/7/732/htm NA
10236 Monovalent GI.1 VLPs Norovirus Infection Gastrointestinal Norovirus positive-sense, single-stranded RNA Virus like particle Phase 1 Baylor College of Medicine, University of Maryland School of Medicine NA USA NA NA Intranasal MPL HuNoV GI.1 NA NA NA NA NA NA NA https://www.mdpi.com/2076-393X/9/7/732/htm NA
10237 Transgenic plant-based norovirus vaccine Norovirus Infection Gastrointestinal Norovirus positive-sense, single-stranded RNA Virus like particle Phase 1 Arizona State University NA USA NA NA Intranasal Gardiquimod, None when delivered with GelVac Norwalk virus (GI.1) VLP Tobacco mosaic virus derived transient expression system using leaves of Nicotiana benthamiana NA NA NA NA NA NA https://www.cdc.gov/norovirus/downloads/global-burden-report.pdf NA
10250 COVID-19 Vaccine Nasal Spray COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Phase 2 Xiamen University 2021 China 18 years and above 2 doses 14 days apart Intranasal NA NA NA NA University of Hong Kong, Beijing Wantai Biological Pharmacy NA NA 33937326 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082173/ NA
10264 DelNS1-2019-nCoV-RBD-OPT1 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Replicating viral vector Phase 2 Beijing Wantai Biological NA NA NA Single dose Intranasal NA NA NA NA Jiangsu Province Centers for Disease Control and Prevention NA NA 33816047 NCT04809389 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ https://clinicaltrials.gov/ct2/show/NCT04809389
10280 AV-COVID-19 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Phase 2 Aivita Biomedical Inc. 2020 USA 18 years and above NA Intranasal GM-CSF Spike protein of SARS-CoV-2 virus NA US FDA NA NA NA NA NCT05007496 https://clinicaltrials.gov/show/NCT04386252 https://clinicaltrials.gov/ct2/show/NCT05007496
10383 NanoVax Genital Herpes Cutaneous Herpes simplex virus double stranded DNA Subunit vaccine Preclinical BlueWillow Biologics NA USA NA NA Intranasal NA Herpes simplex virus 2 glycoprotein D (gD-2) NA NA NA NA NA NA NA https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates NA
10419 GII.4 P particles Norovirus Infection Gastrointestinal Norovirus positive-sense, single-stranded RNA Virus like particle Preclinical Cincinnati Children’s Hospital Medical Center NA USA NA NA Intranasal NA P particles derived from HuNoV VP1 NA NA Southern Medical University, Virginia Polytechnic Institute and State University NA NA NA NA https://www.mdpi.com/2076-393X/9/7/732/htm https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851174/
10420 Plant-expressed GII.4 VLPs Norovirus Infection Gastrointestinal Norovirus positive-sense, single-stranded RNA Virus like particle Preclinical Arizona State University NA USA NA NA Intranasal NA HuNoV GII.4 VLP NA NA NA NA NA NA NA https://www.mdpi.com/2076-393X/9/7/732/htm https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054422/
10422 Norovirus P particle and combination vaccines Norovirus Infection Gastrointestinal Norovirus positive-sense, single-stranded RNA Subunit vaccine Preclinical Cincinnati Children’s Hospital Medical Center NA USA NA NA Intranasal Chitosan, MPL and TNC buffer P domains representing different GI and GII strains Baculovirus vector in E.coli or yeast system NA NA NA NA NA NA https://www.cdc.gov/norovirus/downloads/global-burden-report.pdf NA